Medtronic (MDT) Stock Forecast & Price Target

Compare

6,276 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MDT Analyst Ratings

Moderate Buy

12 Buy

12 Hold

1 Sell

Based on 25 analysts giving stock ratings to

Medtronic

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MDT Stock 12 Month Forecast

Average Price Target

$101.37

▲(6.20% Upside)

Based on 25 Wall Street analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $101.37 with a high forecast of $115.00 and a low forecast of $78.00. The average price target represents a 6.20% change from the last price of $95.45.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"77":"$77","116":"$116","86.75":"$86.8","96.5":"$96.5","106.25":"$106.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":115,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$115.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":101.37,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$101.37</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":78,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$78.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[77,86.75,96.5,106.25,116],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,94.81,96.36307692307693,97.91615384615385,99.46923076923078,101.02230769230769,102.57538461538462,104.12846153846154,105.68153846153847,107.23461538461538,108.78769230769231,110.34076923076923,111.89384615384616,113.44692307692307,{"y":115,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,94.81,95.3146153846154,95.81923076923077,96.32384615384616,96.82846153846154,97.33307692307693,97.83769230769231,98.3423076923077,98.84692307692308,99.35153846153847,99.85615384615384,100.36076923076924,100.86538461538461,{"y":101.37,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,94.81,93.51692307692308,92.22384615384615,90.93076923076923,89.6376923076923,88.34461538461538,87.05153846153846,85.75846153846155,84.46538461538462,83.1723076923077,81.87923076923077,80.58615384615385,79.29307692307692,{"y":78,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":87.14,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.2,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.78,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.01,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.69,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.86,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.1,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.25,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.42,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.08,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 53,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.67,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.63,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.81,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$115.00

Average Price Target$101.37

Lowest Price Target$78.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Shagun Singh Chadha

RBC Capital

$103→$111

Buy

16.29%

Upside

Reiterated

10/10/25

Medtronic price target raised to $111 from $103 at RBC CapitalMedtronic price target raised to $111 from $103 at RBC Capital

Matthew O'Brien

Piper Sandler

$90

Hold

-5.71%

Downside

Reiterated

10/10/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NASDAQ: NEOG), Medtronic (NYSE: MDT) and Merck & Company (NYSE: MRK)

Joanne Wuensch

Citi

$101→$112

Buy

17.34%

Upside

Assigned

10/09/25

Medtronic price target raised to $112 from $101 at CitiMedtronic price target raised to $112 from $101 at Citi

Josh Jennings

TD Cowen

$106

Buy

11.05%

Upside

Reiterated

10/09/25

Medtronic's Strategic Positioning and Innovative Solutions Drive Buy Rating

Patrick Wood

Morgan Stanley

$107

Buy

12.10%

Upside

Reiterated

10/09/25

Medtronic's Altaviva Device: A Promising Market Expansion with Competitive Advantages

Ryan Zimmerman

BTIG

―

Hold

―

Reiterated

10/09/25

Medtronic's Hold Rating: Balancing Promising Innovations with Market Challenges

Rick Wise

Stifel Nicolaus

$90→$105

Hold

10.01%

Upside

Reiterated

10/08/25

Medtronic price target raised to $105 from $90 at StifelMedtronic price target raised to $105 from $90 at Stifel

Travis Steed

Bank of America Securities

$100

Buy

4.77%

Upside

Reiterated

09/25/25

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Medtronic (NYSE: MDT)

Lee Hambright

Bernstein

$98

Buy

2.67%

Upside

Reiterated

09/08/25

Bernstein Remains a Buy on Medtronic (MDT)We rate ABT, BSX, DXCM, ISRG, MDT, SYK, and PODD Outperform.

Mike Kratky

Leerink Partners

$111

Buy

16.29%

Upside

Reiterated

09/02/25

Medtronic's Strategic M&A Shift and Growth Potential Boost Buy Rating

Lila Implantra

TR | OpenAI - 4o

$107

Buy

12.10%

Upside

Reiterated

08/29/25

AI Generated ArticleAI Generated Article

David Toung

Argus Research

$115

Buy

20.48%

Upside

Reiterated

08/25/25

Medtronic price target raised to $115 from $105 at ArgusMedtronic price target raised to $115 from $105 at Argus

Michael Polark

Wolfe Research

―

Hold

―

Reiterated

08/25/25

Wolfe Research Sticks to Their Hold Rating for Medtronic (MDT)Wolfe Research analyst Mike Polark reiterated a Peerperform rating on Medtronic, Inc. (NYSE: MDT).

Richard Newitter

Truist Financial

$92→$96

Hold

0.58%

Upside

Reiterated

08/21/25

Truist Financial Sticks to Their Hold Rating for Medtronic (MDT)

Matt Miksic

Barclays

$109

Buy

14.20%

Upside

Reiterated

08/20/25

Medtronic (MDT) Gets a Buy from Barclays

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Shagun Singh Chadha

RBC Capital

$103→$111

Buy

16.29%

Upside

Reiterated

10/10/25

Medtronic price target raised to $111 from $103 at RBC CapitalMedtronic price target raised to $111 from $103 at RBC Capital

Matthew O'Brien

Piper Sandler

$90

Hold

-5.71%

Downside

Reiterated

10/10/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NASDAQ: NEOG), Medtronic (NYSE: MDT) and Merck & Company (NYSE: MRK)

Joanne Wuensch

Citi

$101→$112

Buy

17.34%

Upside

Assigned

10/09/25

Medtronic price target raised to $112 from $101 at CitiMedtronic price target raised to $112 from $101 at Citi

Josh Jennings

TD Cowen

$106

Buy

11.05%

Upside

Reiterated

10/09/25

Medtronic's Strategic Positioning and Innovative Solutions Drive Buy Rating

Patrick Wood

Morgan Stanley

$107

Buy

12.10%

Upside

Reiterated

10/09/25

Medtronic's Altaviva Device: A Promising Market Expansion with Competitive Advantages

Ryan Zimmerman

BTIG

―

Hold

―

Reiterated

10/09/25

Medtronic's Hold Rating: Balancing Promising Innovations with Market Challenges

Rick Wise

Stifel Nicolaus

$90→$105

Hold

10.01%

Upside

Reiterated

10/08/25

Medtronic price target raised to $105 from $90 at StifelMedtronic price target raised to $105 from $90 at Stifel

Travis Steed

Bank of America Securities

$100

Buy

4.77%

Upside

Reiterated

09/25/25

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Medtronic (NYSE: MDT)

Lee Hambright

Bernstein

$98

Buy

2.67%

Upside

Reiterated

09/08/25

Bernstein Remains a Buy on Medtronic (MDT)We rate ABT, BSX, DXCM, ISRG, MDT, SYK, and PODD Outperform.

Mike Kratky

Leerink Partners

$111

Buy

16.29%

Upside

Reiterated

09/02/25

Medtronic's Strategic M&A Shift and Growth Potential Boost Buy Rating

Lila Implantra

TR | OpenAI - 4o

$107

Buy

12.10%

Upside

Reiterated

08/29/25

AI Generated ArticleAI Generated Article

David Toung

Argus Research

$115

Buy

20.48%

Upside

Reiterated

08/25/25

Medtronic price target raised to $115 from $105 at ArgusMedtronic price target raised to $115 from $105 at Argus

Michael Polark

Wolfe Research

―

Hold

―

Reiterated

08/25/25

Wolfe Research Sticks to Their Hold Rating for Medtronic (MDT)Wolfe Research analyst Mike Polark reiterated a Peerperform rating on Medtronic, Inc. (NYSE: MDT).

Richard Newitter

Truist Financial

$92→$96

Hold

0.58%

Upside

Reiterated

08/21/25

Truist Financial Sticks to Their Hold Rating for Medtronic (MDT)

Matt Miksic

Barclays

$109

Buy

14.20%

Upside

Reiterated

08/20/25

Medtronic (MDT) Gets a Buy from Barclays

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medtronic

1 Month

xxx

Success Rate

19/30 ratings generated profit

Average Return

+1.59%

reiterated a xxx

rating 4 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 63.33% of your transactions generating a profit, with an average return of +1.59% per trade.

3 Months

xxx

Success Rate

17/22 ratings generated profit

Average Return

+4.60%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 77.27% of your transactions generating a profit, with an average return of +4.60% per trade.

1 Year

Larry BiegelsenWells Fargo

Success Rate

25/30 ratings generated profit

Average Return

+9.51%

reiterated a buy rating 2 months ago

Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +9.51% per trade.

2 Years

xxx

Success Rate

24/26 ratings generated profit

Average Return

+14.15%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 92.31% of your transactions generating a profit, with an average return of +14.15% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MDT Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MDT has received 31 Buy Ratings, 16 Hold Ratings, and 1 Sell Ratings. MDT average Analyst price target in the past 3 months is 101.37.

Each month's total comprises the sum of three months' worth of ratings.

MDT Financial Forecast

MDT Earnings Forecast

Next quarter’s earnings estimate for MDT is $1.31 with a range of $1.31 to $1.32. The previous quarter’s EPS was $1.26. MDT beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year MDT has Outperformed its overall industry.

MDT Sales Forecast

Next quarter’s sales forecast for MDT is $8.87B with a range of $8.82B to $8.91B. The previous quarter’s sales results were $8.58B. MDT beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MDT has Outperformed its overall industry.

MDT Stock Forecast FAQ

What is MDT’s average 12-month price target, according to analysts?

Based on analyst ratings, Medtronic’s 12-month average price target is 101.37.

What is MDT’s upside potential, based on the analysts’ average price target?

Medtronic has 6.20% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MDT a Buy, Sell or Hold?

Medtronic has a consensus rating of Moderate Buy which is based on 12 buy ratings, 12 hold ratings and 1 sell ratings.

What is Medtronic’s price target?

The average price target for Medtronic is 101.37. This is based on 25 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $115.00 ,the lowest forecast is $78.00. The average price target represents 6.20% Increase from the current price of $95.45.

What do analysts say about Medtronic?

Medtronic’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 25 Wall Streets Analysts.

How can I buy shares of MDT?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Medtronic (MDT) Stock Forecast & Price Target

MDT Analyst Ratings

MDT Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Medtronic

MDT Analyst Recommendation Trends

MDT Financial Forecast

MDT Earnings Forecast

MDT Sales Forecast

MDT Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts